International Journal of Personalized Medicine
Publishing transformative research in pharmacogenomics, molecular diagnostics, targeted therapies, biomarker discovery, and precision oncology advancing personalized treatment strategies that improve patient outcomes through individualized care based on genetic profiling molecular characteristics and predictive analytics.
What You Gain
- Indexed in PubMed, Scopus, Embase
- NIH precision medicine initiative compliant
- Permanent DOI for stable citations
- Author retains full copyright
- Free genomic data visualization
- 24hr editorial support response
Career-Changing Benefits
Tangible professional advantages when you publish your precision medicine research
From Submission to CV Citation
Transparent timeline showing your research path to publication
How Publication Accelerates Careers
Data from precision medicine researchers who published with us
Precision Medicine Topics We Publish
Comprehensive scope across personalized healthcare applications
Pharmacogenomics
CYP450 genetic variants, drug metabolism polymorphisms, adverse drug reaction prediction, warfarin dosing algorithms, clopidogrel resistance, opioid sensitivity, chemotherapy toxicity prevention personalized medication selection
Precision Oncology
Tumor mutational profiling, liquid biopsies, circulating tumor DNA, PD-L1 expression, microsatellite instability, BRCA testing, targeted therapy selection, immunotherapy biomarkers, minimal residual disease monitoring treatment response prediction
Cardiovascular Genomics
Familial hypercholesterolemia genetic screening, polygenic risk scores, sudden cardiac death prevention, cardiomyopathy variants, arrhythmia susceptibility, statin response prediction, hypertension pharmacogenomics precision prevention strategies
Rare Disease Diagnosis
Whole exome sequencing, whole genome sequencing, undiagnosed disease programs, molecular diagnosis, gene panel testing, variant interpretation, newborn screening expansion, orphan drug development precision therapy matching
Infectious Disease
HIV treatment individualization, tuberculosis drug resistance prediction, antimicrobial stewardship, sepsis biomarkers, COVID-19 severity prediction, vaccine response genetics, transplant recipient monitoring pathogen genomics
Digital Health Integration
Wearable biosensors, continuous monitoring, AI-driven risk prediction, electronic health record genomic integration, clinical decision support, telemedicine genomics, mobile health apps, patient portals precision medicine delivery
How Authors Advanced Their Careers
Real outcomes from precision medicine researchers who published with us
Published pharmacogenomic warfarin dosing algorithm study. Downloaded 18000 times globally, cited 425 times in 20 months, invited speaker at 12 international conferences, promoted to Full Professor 3 years ahead of schedule, received $3.2M NIH R01 grant to expand research.
Liquid biopsy cancer monitoring research featured in Nature News, downloaded by oncologists in 65 countries, led to pharma partnerships with 3 biotech companies, invited to FDA advisory panel, launched clinical trial at 22 cancer centers implementing findings.
Comprehensive Support Services
Professional bioinformatics support for complex genomic datasets including variant visualization, pathway enrichment plots, mutation signatures, phylogenetic trees, protein structure modeling, and multi-omic integration graphics ensuring maximum clarity and publication-ready figures that reviewers and readers can easily interpret and appreciate.
Complimentary expert review of study design, sample size calculations, multiple testing corrections, survival analysis, machine learning model validation, omics data analysis pipelines, and statistical methods ensuring appropriate methodology selection preventing reviewer critiques and strengthening conclusions supporting rapid acceptance and high citation impact.
Assistance with genomic data deposition to dbGaP, ClinVar, GEO, ArrayExpress, PDB ensuring Findable Accessible Interoperable Reusable principles met, permanent accession numbers obtained, metadata standardization, and funder requirements satisfied including NIH genomic data sharing policy compliance maximizing data reuse and secondary citations.
For breakthrough precision medicine discoveries requiring rapid dissemination including novel biomarkers, therapeutic targets, drug resistance mechanisms, or clinical trial results, we offer fast-track review with first decision in 10 days and publication within 3 weeks ensuring timely knowledge translation, citation priority, and competitive advantage in rapidly evolving personalized healthcare field.
Why Precision Medicine Leaders Choose Open Access
Membership Tiers
Select your publication tier based on research output goals
Publish Your Precision Medicine Research
Submit your genomic medicine research for expert peer review and immediate global open access distribution advancing personalized healthcare and improving patient outcomes worldwide.